AutoAbs against RELT represented the most prominent prognostic indicator for breast cancer in this study, as autoantibodies against RELT alone could diagnose breast cancer with a diagnostic accuracy of 71%, though it should be emphasized that separate studies identified autoAbs against other proteins as more predictive of breast cancer [79,80]. The gene discussed is RELT; the disease is breast cancer.